Development and characterization of solid lipid nanoparticles for enhancement of oral bioavailability of Raloxifene

The objective of this study was to increase the oral bioavailability of Raloxifene having an absolute bioavailability only 2% due to extensive first pass hepatic metabolism by incorporating it in Solid Lipid Nanoparticles (SLNs). The optimized RSLNs prepared by Ultrasonic Emulsification and Low Temp...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, B. Divyakant, Modi, R. Valay, Thakkar, N. Alok, Patel, A. Arpita, Thakkar, P. Hetal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Original/Brief
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467810/
https://www.ncbi.nlm.nih.gov/pubmed/23066188
http://dx.doi.org/10.4103/0975-7406.94121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467810/
https://www.ncbi.nlm.nih.gov/pubmed/23066188
http://dx.doi.org/10.4103/0975-7406.94121

Ejemplares similares